Inmed Pharmaceuticals Inc.
SEC CIK 1728328 · INM · last insider filing 2026-06-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Klompas Neil A | Director | filed 2025 - 2025 |
| Adams Eric A | Director · President & CEO | filed 2020 - 2025 |
| Hull Andrew | Director | filed 2020 - 2025 |
| Lemerond Nicole | Director | filed 2022 - 2025 |
| Bathery John Steven | Director | filed 2025 - 2025 |
| Grove Janet P | Director | filed 2022 - 2024 |
| Baldasare Bryan T | Director | filed 2022 - 2024 |
| Garner William J | Director | filed 2020 - 2022 |
| Cutler Adam D. | Director | filed 2020 - 2022 |
| Sazdanoff Catherine | Director | filed 2020 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| HSU Eric C | Sr. VP, Pre-Clinical Res/Dev | filed 2020 - 2025 |
| Woudenberg Michael | VP, Chem/Manufacturing/Control | filed 2020 - 2025 |
| Johnson Shane Aaron | Sr. VP & General Manager | filed 2021 - 2025 |
| Jagpal Netta | Chief Financial Officer | filed 2024 - 2025 |
| Mancini Alexandra Diane Janet | Sr VP, Clinical/Reg Affairs | filed 2020 - 2024 |
| Tegge Jonathan | Interim CFO | filed 2022 - 2023 |
| Li Sarah | VP, Accounting and Controller | filed 2022 - 2022 |
| Edwards Brenda | Interim CFO | filed 2022 - 2022 |
| Colwill Bruce | CFO | filed 2020 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.